[1]
P. Pandey, A. Asava, K. H. Nagaraj, S. K. Rath, and V. L. Kodati, “A prospective, single-arm, open-label study to determine the safety and effectiveness of a fixed-dose combination of camylofin and mefenamic acid in Indian women with primary dysmenorrhea”, Int J Reprod Contracept Obstet Gynecol, vol. 10, no. 9, pp. 3336–3341, Aug. 2021.